Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
Cesar A. Santa‐Maria(Johns Hopkins University), Vered Stearns(Johns Hopkins University), Amanda L. Blackford(Johns Hopkins University), Todd C. Skaar(Indiana University School of Medicine), Anne Nguyen(Indiana University School of Medicine), Wendy S. Post(Johns Hopkins University), James M. Rae(University of Michigan), Anna Maria Storniolo(Indiana University Health), N. Lynn Henry(University of Michigan), Daniel F. Hayes(University of Michigan–Ann Arbor), Pamela Ouyang(Johns Hopkins University), Santosh Philips(Indiana University School of Medicine), Zeruesenay Desta(Indiana University School of Medicine), Roger S. Blumenthal(Johns Hopkins University), Steffi Oesterreich(University of Pittsburgh), David A. Flockhart(Indiana University – Purdue University Indianapolis), Jason Robarge(Washington University in St. Louis)
Cited by 23
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k